PPA
DVAX

Parametric Portfolio Associates’s Dynavax Technologies DVAX Stock Holding History

Parametric Portfolio Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.32M Buy
121,455
+45,756
+60% +$556K ﹤0.01% 2648
2021
Q4 		$1.06M Sell
75,699
-72,088
-49% -$1.19M ﹤0.01% 2754
2021
Q3 		$2.84M Sell
147,787
-21,168
-13% -$281K ﹤0.01% 2196
2021
Q2 		$1.66M Sell
168,955
-16,416
-9% -$149K ﹤0.01% 2532
2021
Q1 		$1.82M Buy
185,371
+121,716
+191% +$1M ﹤0.01% 2841
2020
Q4 		$283K Buy
63,655
+27,040
+74% +$122K ﹤0.01% 3624
2020
Q3 		$158K Sell
36,615
-19,591
-35% -$140K ﹤0.01% 3723
2020
Q2 		$499K Buy
56,206
+38,321
+214% +$194K ﹤0.01% 3277
2020
Q1 		$63K Sell
17,885
-13,027
-42% -$60.4K ﹤0.01% 3803
2019
Q4 		$177K Buy
30,912
+12,734
+70% +$68.1K ﹤0.01% 3769
2019
Q3 		$65K Sell
18,178
-4,570
-20% -$17.7K ﹤0.01% 3884
2019
Q2 		$91K Sell
22,748
-613
-3% -$3.55K ﹤0.01% 3851
2019
Q1 		$171K Sell
23,361
-2,220
-9% -$21.7K ﹤0.01% 3745
2018
Q4 		$234K Sell
25,581
-23,674
-48% -$262K ﹤0.01% 3602
2018
Q3 		$611K Sell
49,255
-8,070
-14% -$109K ﹤0.01% 3334
2018
Q2 		$874K Buy
57,325
+26,916
+89% +$465K ﹤0.01% 3118
2018
Q1 		$604K Sell
30,409
-2,802
-8% -$48.4K ﹤0.01% 3253
2017
Q4 		$621K Sell
33,211
-57,276
-63% -$1.15M ﹤0.01% 3232
2017
Q3 		$1.95M Buy
90,487
+59,732
+194% +$945K ﹤0.01% 2606
2017
Q2 		$297K Buy
30,755
+3,604
+13% +$23.4K ﹤0.01% 3635
2017
Q1 		$162K Buy
27,151
+939
+4% +$4.51K ﹤0.01% 3638
2016
Q4 		$104K Buy
+26,212
New +$192K ﹤0.01% 3703
2016
Q1 		– Sell
-17,298
Closed -$418K – 3986
2015
Q4 		$418K Buy
+17,298
New +$433K ﹤0.01% 3370
2014
Q4 		– Sell
-3,241
Closed -$46K – 3985
2014
Q3 		$46K Buy
+3,241
New +$46.7K ﹤0.01% 3777
2014
Q2 		– Sell
-1,138
Closed -$21K – 3743
2014
Q1 		$21K Buy
+1,138
New +$21.1K ﹤0.01% 3812

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Parametric Portfolio Associates's DVAX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Dynavax Technologies (DVAX) stake by 60% in Q1 2022, buying an estimated $556K and bringing the position to 121,455 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

Parametric Portfolio Associates first reported a position in DVAX in Q1 2014 and has held it in 25 quarters since. The position peaked at $2.84M in Q3 2021. 207 funds tracked by Wall St. Rank hold DVAX as of Q1 2022.

  • Parametric Portfolio Associates held 121,455 shares of Dynavax Technologies worth $1.32M as of Q1 2022.
  • Parametric Portfolio Associates bought 45,756 Dynavax Technologies shares in Q1 2022, an estimated $556K.
  • Dynavax Technologies made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2648 holding.
  • Parametric Portfolio Associates first reported a position in Dynavax Technologies in Q1 2014 and has held it in 25 quarters since.
  • Parametric Portfolio Associates's Dynavax Technologies position peaked at $2.84M in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.